CHEMBL4442990
General
Type : Cannabinoid-Receptor-ligand,Benzofuran,Multitarget
Chemical_Nomenclature : [4-[(4-fluorophenyl)methylamino]phenyl]-[2-(4-methoxyphenyl)-1-benzofuran-3-yl]methanone
Canonical SMILES : COC1=CC=C(C=C1)C2=C(C3=CC=CC=C3O2)C(=O)C4=CC=C(C=C4)NCC5=CC=C(C=C5)F
InChI : InChI=1S\/C29H22FNO3\/c1-33-24-16-10-21(11-17-24)29-27(25-4-2-3-5-26(25)34-29)28(32)20-8-14-23(15-9-20)31-18-19-6-12-22(30)13-7-19\/h2-17,31H,18H2,1H3
InChIKey : DGMAZLYSMDRMCJ-UHFFFAOYSA-N
Other name(s) : BDBM50516290,compound 8,(4-((4-Fluorobenzyl)amino)phenyl)(2-(4-methoxyphenyl)benzofuran-3-yl)methanone
MW : 451.5
Formula : C29H22FNO3
CAS_number :
PubChem : 155516090
UniChem : DGMAZLYSMDRMCJ-UHFFFAOYSA-N
IUPHAR :
Wikipedia :
Target
References (1)
| Title : Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment - Montanari_2019_Eur.J.Med.Chem_178_243 |
| Author(s) : Montanari S , Mahmoud AM , Pruccoli L , Rabbito A , Naldi M , Petralla S , Moraleda I , Bartolini M , Monti B , Iriepa I , Belluti F , Gobbi S , Di Marzo V , Bisi A , Tarozzi A , Ligresti A , Rampa A |
| Ref : Eur Journal of Medicinal Chemistry , 178 :243 , 2019 |
| Abstract : Montanari_2019_Eur.J.Med.Chem_178_243 |
| ESTHER : Montanari_2019_Eur.J.Med.Chem_178_243 |
| PubMedSearch : Montanari_2019_Eur.J.Med.Chem_178_243 |
| PubMedID: 31185414 |